Novo Nordisk Other Operating Income or Expenses 2010-2024 | NVO
Novo Nordisk other operating income or expenses for the twelve months ending June 30, 2024 were $-0.010B, a 113.92% decline year-over-year.
- Novo Nordisk annual other operating income or expenses for 2023 were $0.017B, a 88.2% decline from 2022.
- Novo Nordisk annual other operating income or expenses for 2022 were $0.146B, a 177.19% increase from 2021.
- Novo Nordisk annual other operating income or expenses for 2021 were $0.053B, a 25.05% decline from 2020.